Shuihong Cheng
Beijing, 100101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Single-Dose Oral Influenza Antiviral Prodrug Enabled by Cholesterol Conjugation.
Journal: Journal of medicinal chemistry
Published: October 03, 2025
Polysaccharide conjugate vaccines: From historical milestones to future strategies.
Journal: Carbohydrate polymers
Published: July 16, 2025
Development of novel antivrial agents that induce the degradation of the main protease of human-infecting coronaviruses.
Journal: European journal of medicinal chemistry
Published: April 22, 2024
Glycan-Modified Peptides for Dual Inhibition of Human Immunodeficiency Virus Entry into Dendritic Cells and T Cells.
Journal: Journal of medicinal chemistry
Published: February 16, 2024
Improving Anti-HIV activity and pharmacokinetics of enfuvirtide (T20) by modification with oligomannose.
Journal: European journal of medicinal chemistry
Published: January 11, 2024
Kinetic and Structural Aspects of Glycosaminoglycan-Monkeypox Virus Protein A29 Interactions Using Surface Plasmon Resonance.
Journal: Molecules (Basel, Switzerland)
Published: August 19, 2022
Zanamivir-Cholesterol Conjugate: A Long-Acting Neuraminidase Inhibitor with Potent Efficacy against Drug-Resistant Influenza Viruses.
Journal: Journal of medicinal chemistry
Published: November 19, 2021
Polyethylene Glycol 40-Modified Peptide with High Therapeutic Efficacy in Simian-Human Immunodeficiency Virus-Acutely Infected Rhesus Monkeys.
Journal: Journal of virology
Published: March 04, 2020
Comparison of the Interactions of Different Growth Factors and Glycosaminoglycans.
Journal: Molecules (Basel, Switzerland)
Published: August 20, 2019
Long-Acting HIV-1 Fusion Inhibitory Peptides and their Mechanisms of Action.
Journal: Viruses
Published: July 30, 2019
Synthesis and biological evaluation of neoglycosphingolipids.
Journal: European journal of medicinal chemistry
Published: January 03, 2017
Enfuvirtide-PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties.
Journal: European journal of medicinal chemistry
Published: February 25, 2016
Last Updated: 09/26/2026